Adam King
Nessuna posizione attualmente
Patrimonio netto: 172 125 $ in data 31/03/2024
Profilo
Mr. Adam King, CPA, is a Chief Financial & Accounting Officer at QSAM Biosciences, Inc. and a Chief Executive Officer at King Consulting Group.
Mr. King was previously employed as a Chief Financial Officer by Netsertive, Inc., a Director-Revenue Assurance & Internal Controls by Bandwidth.com CLEC LLC, and an Audit Manager by Ernst & Young LLP.
He received his undergraduate degree from Elon University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.52% | 08/04/2024 | 22 950 ( 0.52% ) | 172 125 $ | 31/03/2024 |
Posizioni attive di Adam King
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Adam King
| Società | Posizione | Fine |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Director of Finance/CFO | 02/05/2024 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/06/2014 |
Formazione di Adam King
| Elon University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
- Borsa valori
- Insiders
- Adam King
